These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1818949)

  • 1. Effect of the angiotensin antagonist DuP 753 on the renal adaptation to sodium restriction in the rat.
    Jover B; Dupont M; Nafrialdi E; Mimran A
    J Hypertens Suppl; 1991 Dec; 9(6):S210-1. PubMed ID: 1818949
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of inhibitory potency by nonpeptide angiotensin II receptor antagonists PD123177 and DuP 753 on proximal nephron and renal transport.
    Cogan MG; Liu FY; Wong PC; Timmermans PB
    J Pharmacol Exp Ther; 1991 Nov; 259(2):687-91. PubMed ID: 1941617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
    Jover B; Saladini D; Nafrialdi N; Dupont M; Mimran A
    Am J Physiol; 1994 Aug; 267(2 Pt 2):F281-8. PubMed ID: 8067389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Losartan prevents salt-induced hypertension in reduced renal mass rats.
    Kanagy NL; Fink GD
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1131-6. PubMed ID: 8509998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II receptors and angiotensin II receptor antagonists.
    Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
    Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
    [No Abstract]   [Full Text] [Related]  

  • 6. DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan.
    Goldberg MR; Lo MW; Christ DD; Chiou R; Furtek CI; Amit O; Carides A; Biollaz J; Piguet V; Nussberger J; Brunner HR
    Clin Pharmacol Ther; 1997 Jan; 61(1):59-69. PubMed ID: 9024174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin antagonists.
    Brunner HR; Nussberger J; Waeber B
    Adv Nephrol Necker Hosp; 1993; 22():305-27. PubMed ID: 8427061
    [No Abstract]   [Full Text] [Related]  

  • 8. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats.
    Lo M; Liu KL; Lantelme P; Sassard J
    J Clin Invest; 1995 Mar; 95(3):1394-7. PubMed ID: 7883985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive and renal-protective effects of losartan in streptozotocin diabetic rats.
    Kohzuki M; Yasujima M; Kanazawa M; Yoshida K; Fu LP; Obara K; Saito T; Abe K
    J Hypertens; 1995 Jan; 13(1):97-103. PubMed ID: 7759858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonpeptide angiotensin II antagonists].
    Shionoiri H; Takasaki I; Sugimoto K; Minamisawa K
    Nihon Rinsho; 1992 Apr; 50 Suppl():753-63. PubMed ID: 1635263
    [No Abstract]   [Full Text] [Related]  

  • 11. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hormonal contribution to short-term variability of blood pressure in a renovascular hypertension model].
    Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1203-7. PubMed ID: 8572874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the angiotensin II receptor antagonist MK 954 on the angiotensin II-induced increase in free cytosolic Ca2+ and growth in vascular smooth muscle cells.
    Sachinidis A; Görg A; Ko Y; Wieczorek AJ; Düsing R; Vetter H
    J Hypertens Suppl; 1991 Dec; 9(6):S226-7. PubMed ID: 1818954
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute myocardial and vascular responses to specific angiotensin II antagonism in the spontaneously hypertensive rat.
    Cody RJ; Binkley PF; Haas GJ; Brown DM
    Am J Hypertens; 1995 May; 8(5 Pt 1):500-8. PubMed ID: 7662227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dahl salt-sensitive rats.
    Lark LA; Wappel SM; Weyhenmeyer JA
    J Pharmacol Exp Ther; 1995 Aug; 274(2):745-51. PubMed ID: 7636738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the specific angiotensin II receptor antagonist losartan on urate homeostasis and intestinal urate transport.
    Hatch M; Freel RW; Shahinfar S; Vaziri ND
    J Pharmacol Exp Ther; 1996 Jan; 276(1):187-93. PubMed ID: 8558429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time course of losartan blockade of angiotensin II hypertension versus blockade of angiotensin II fast pressor effects.
    Gorbea-Oppliger VJ; Melaragno MG; Potter GS; Petit RL; Fink GD
    J Pharmacol Exp Ther; 1994 Nov; 271(2):804-10. PubMed ID: 7965799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat.
    Macari D; Bottari S; Whitebread S; De Gasparo M; Levens N
    Eur J Pharmacol; 1993 Nov; 249(1):85-93. PubMed ID: 8282023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta adrenoceptor blockade in rabbit inhibits the renin-releasing effect of AT1 receptor antagonist losartan.
    Hajj-Ali AF; Wong PC
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1423-7. PubMed ID: 7903389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with angiotensin II receptor antagonists.
    Lee RJ; Brunner HR
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S33-6. PubMed ID: 8230087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.